Process of Regulation in Addictions: Vulnerability Emotional Factors to Craving

Overview

The aim of this study is to have a better understanding of the relationship between self-controle difficulties (and more specifically the inhibition deficit in impulsivity), emotional regulation disorders such as alexithymia and craving.This study will be the first in France to specify the interactions between self-regulkation processes dysfunctions and emotional dysfunctions in craving.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: November 20, 2020

Detailed Description

The main objective is to measure the level of cocaine craving, 6 months after the end of their detoxification treatment (outpatient or full hospitalization), in patients with a diagnosis of moderate to severe dependence (DSM 5) to cocaine and co-addiction, or not, to alcohol and / or psychostimulants. To evaluate cocaïne craving,the questionnaire CCQ-Brief will be used.

Interventions

  • Behavioral: Patients with completed rehab
    • The main objective is to measure the level of cocaine craving, 6 months after the end of their detoxification treatment (outpatient or full hospitalization), in patients with a diagnosis of moderate to severe dependence (DSM 5) to cocaine and co-addiction, or not, to alcohol and / or psychostimulants. To evaluate cocaïne craving,the questionnaire CCQ-Brief will be used.

Arms, Groups and Cohorts

  • Experimental: Patients with completed rehab
    • The aim of this research is to follow-up a cohort of patients at the end of their detoxification cure (cocaïne).

Clinical Trial Outcome Measures

Primary Measures

  • Cocaïne craving evaluation
    • Time Frame: 6 months
    • Using the French version of the questionnaire CCQ-Brief “Cocaïne Craving Questionnaire”.

Participating in This Clinical Trial

Inclusion Criteria

  • Patient, men or women between 18 and 60 years-old – Patient with a diagnosis of moderate to severe dependence (DSM 5) to cocaine with or without co-addictions to alcohol or psychostimulant. – Patient on day-hospitalisation or full hospitalisation – Patient affiliated or beneficiary to a social security scheme. – Patient having signed the free and informed consent. Exclusion Criteria:

  • Patient with psychiatric disorders psychosis type – Patient with severe chronic somatic disease. – Patient participating in another clinical study – Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision. – Pregnant, breastfeeding or parturient woman. – Patient hospitalized without consent.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 60 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ramsay Générale de Santé
  • Collaborator
    • Ramsay santé
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Jean-François Oudet, 06 83 34 65 67, jf.oudet@ecten.eu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.